BK virus replication in vitro: Limited effect of drugs interfering with viral uptake and intracellular transport

Antimicrobial Agents and Chemotherapy

Volumn 51, Issue 12, 2007, Pages 4492-4494

  Randhawa, Parmjeet ^a   Farasati, Noush Afarin ^a   Huang, Yuchen ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (HYDROXYMETHYL 6 (OCTYLOXY)TETRAHYDRO 2H PYRAN 3,4,5 TRIOL; 2 (HYDROXYMETHYL) 6 (NONYLOXY)TETRAHYDRO 2H PYRAN 3,4,5 TRIOL; 2 HYDROXYMETHYL 6 METHOXYTETRAHYDRO 2H PYRAN 3,4,5 TRIOL; 3,4,5 TRIACETOXY 2 (ACETOXYMETHYL)TETRAHYDROPYRAN; 3,4,5 TRIACETOXY 2 (ACETYLOXYMETHYL)TETRAHYDROPYRAN; 3,4,5,6 TETRAHYDROXYTETRAHYDRO 2H PYRAN 2 CARBOXYLIC ACID; AMPHOTERICIN B; BTB 11967; BTB 11968; CHLOROQUINE; CHLORPROMAZINE; CLOZAPINE; COLCHICINE; JFD 03599; METHYL 3,4,5,6 TETRA(ACETYLOXY)TETRAHYDRO 2H PYRAN 2 CARBOXYLATE; METHYL 3,4,5,6 TETRAHYDROXYTETRAHYDRO 2H PYRAN 2 CARBOXYLATE; NRB 05157; NRB 05166; NRB 05186; NYSTATIN; OLANZAPINE; RISPERIDONE; RJC 00828; RJC 01352; RJC 01353; SIALIC ACID DERIVATIVE; TUNICAMYCIN; UNCLASSIFIED DRUG; ZIPRASIDONE;

ANTIVIRAL ACTIVITY; ARTICLE; BK VIRUS; DRUG STRUCTURE; EMBRYO; GRAFT RECIPIENT; HUMAN; HUMAN CELL; IN VITRO STUDY; KIDNEY GRAFT; PRIORITY JOURNAL; VIRUS REPLICATION;

ANTIVIRAL AGENTS; BK VIRUS; CELL LINE; CHLOROQUINE; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR STRUCTURE; NYSTATIN; VIRUS REPLICATION;

EID: 36749031107     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00843-07     Document Type: Article

References (21)

1. Anderson, H. A., Y. Chen, and L. C. Norkin. 1996. Bound simian virus 40 translocates to caveolin-enriched membrane domains, and its entry is inhibited by drugs that selectively disrupt caveolae. Mol. Biol. Cell. 7:1825-1834.
2. Berndt, T. J., M. Y. Liang, G. M. Tyce, and F. G. Knox. 2001. Intrarenal serotonin, dopamine, and phosphate handling in remnant kidneys. Kidney Int. 59:625-630.
3. Dubois, V., H. Moret, M. E. Lafon, C. B. Janvresse, E. Dussaix, J. Icart, A. Karaterki, A. Ruffault, Y. Taoufik, C. Vignoli, and D. Ingrand. 1998. Prevalence of JC virus viremia in HIV-infected patients with or without neurological disorders - a prospective study. J. Neurovirol. 4:539-544.
4. Dugan, A. S., S. Eash, and W. J. Atwood. 2005. An N-linked glycoprotein with alpha-(2,3)-linked sialic acid is a receptor for BK virus. J. Virol. 79: 14442-14445.
5. Eash, S., and W. J. Atwood. 2005. Involvement of cytoskeletal components in BK virus infectious entry. J. Virol. 79:11734-11741.
6. Elphick, G. F., W. Querbes, J. A. Jordan, G. V. Gee, S. Eash, K. Manley, A. Dugan, M. Stanifer, A Bhatnagar, W. K. Kroeze, B. L. Roth, and W. J. Atwood. 2004. The human Polyomavirus, JCV, uses serotonin receptors to infect cells. Science 306:1380-1383.
7. Farasati, N. A., R. Shapiro, A. Vats, and P. Randhawa. 2005. Effect of leflunomide and cidofovir on replication of BK-virus in an in vitro culture system. Transplantation 79:116-118.
8. Fu, D., and B. D. Roufogalis. 2007. Actin disruption inhibits cndosomal traffic of P-glycoprotcin-EGFP and resistance to daunorubicin accumulation. Am. J. Physiol. Cell Physiol. 292:C1543-1552.
9. Gray, J. A., D. J. Sheffler, A. Bhatnagar, J. A. Woods, S. J. Hufeisen, J. L. Benovic, and B. L. Roth. 2001. Cell-type specific effects of endocytosis inhibitors on 5-hydroxytryptamine(2A) receptor desensitization and resensitization reveal an arrestin-, GRK2-, and GRK5-independent mode of regulation in human embryonic kidney 293 cells. Mol. Pharmacol. 60:1020-1030.
10. Keyaerts, E., L. Vijgen, P. Maes, J. Neyts, and M. V. Ranst. 2004. In vitro inhibition of severe acute respiratory syndrome Coronavirus by chloroquine. Biochem. Biophys. Res. Commun. 323:264-268.
11. Low, J. A., B. Magnuson, B. Tsai, and M. J. Imperiale. 2006. Identification of gangliosides GD1b and GT1b as receptors for BK virus. J. Virol. 80:1361-1366.
12. Ooi, E., J. Chew, J. Loh, and R. Chua. 2006. In vitro inhibition of human influenza A virus replication by chloroquine. Virol. J. 3:39.
13. Randhawa, P., N. Farasati, R. Shapiro, and K. Hostetler. 2006. Ether lipid ester derivatives of cidofovir inhibit Polyomavirus BK replication in vitro. Antimicrob. Agents Chemother. 50:1564-1566.
14. Randhawa, P. S., A. Vats, R. Shapiro, K. Week, and V. Scantlebury. 2002. BK virus: discovery, epidemiology, and biology. Graft 5(Suppl.):S19-S27.
15. Randhawa, P. S., A. Vats, D. Zygmunt, P. A. Swalsky, V. Scantlebury, R. Shapiro, and S. Finkelstein. 2002. Quantitation of viral DNA in renal allograft tissue from patients with BK virus nephropathy. Transplantation 74:485-488.
16. Savarino, A., J. R. Boelaert, A. Cassone, G. Majori, and R. Cauda. 2003. Effects of chloroquine on viral infections: an old drug against today's diseases? Lancet Infect. Dis. 3:722-727.
17. Savarino, A., L. Di Trani, I. Donatelli, R. Cauda, and A. Cassone. 2006. New insights into the antiviral effects of chloroquine. Lancet Infect. Dis. 6:67.
18. Savarino, A., M. B. Lucia, R. ter Heine, E. Rastrelli, S. Rutella, G. Majori, A. Huitema, J. R. Boelaert, and R. Cauda. 2006. Quinoline antimalarials as investigational drugs for HIV-1/AIDS: in vitro effects on HIV-1 replication, HIV-1 response to antiretroviral drugs, and intracellular antiretroviral drug concentrations. Drug Dev. Res. 67:806-817.
19. Shibata, M., H. Aoki, T. Tsurumi, Y. Sugiura, Y. Nishiyama, S. Suzuki, and K. Maeno. 1983. Mechanism of uncoating of influenza B virus in MDCK cells: action of chloroquine. J. Gen. Virol. 64:1149-1156.
20. Tsai, W. P., P. L. Nara, H. F. Kung, and S. Oroszlan. 1990. Inhibition of human immunodeficiency virus infectivity by chloroquine. AIDS Res. Hum. Retroviruses 6:481-489.
21. Vincent, M., E. Bergeron, S. Benjannet, B. Erickson, P. Roll in, T. Ksiazek, N. Seidah, and S. Nichol. 2005. Chloroquine is a potent inhibitor of SARS Coronavirus infection and spread. Virol. J. 2:69.